Homo sapiens versus SARS-CoV-2

Abstract

The current outbreak has led to renewed interest in developing novel disinfectants/drugs to kill “a species” for the benefit of “another species.” While the discovery of new antimicrobials will ensure our ability to counter such threats in the short term, the development of drug resistance through natural selection will lead to the evolution of more “superbugs.” In this regard, there is a need to understand viral perspective and associated molecular mechanisms and whether we can regulate viral strategies for our benefit to coexist in the long term.

Rights

This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.

Cite as

Downloadable citations

Identifiers

DOI

https://doi.org/10.1021/acschemneuro.0c00436

Repository URI

https://researchportal.hw.ac.uk/en/publications/fb839f85-00ce-405a-8aa9-345849f62b83